Zydus Lifesciences recently announced the launch of AI glucose monitors in India. These next-generation Continuous Glucose Monitoring (CGM) devices, Diasens and GlucoLive, aim to transform modern diabetes management. By integrating artificial intelligence, Zydus provides a more connected care ecosystem for patients and clinicians alike. Consequently, this technology bridge improves real-time clinical decision-making.

How AI Glucose Monitors Enhance Patient Care

The new CGM systems stream glucose readings to smartphones every three minutes. Furthermore, this ensures an uninterrupted capture of data, even during the night or in emergencies. The integrated AI layer identifies trends and flags hypoglycemic or hyperglycemic episodes immediately. Additionally, the system links these fluctuations to specific food intake and physical activities. Therefore, clinicians can offer more precise, personalized advice to their patients based on comprehensive glycaemic data. Moreover, the automatic streaming eliminates the need for manual logging by the patient.

Integrating the TatvaCare GoodFlip App

The technology functions through the TatvaCare GoodFlip application. This app generates actionable insights from complex data sets. Because the app shares data in real-time, caregivers and doctors can intervene more quickly. Such advancements simplify the monitoring process for those living with chronic conditions. Moreover, the closed-loop ecosystem ensures that no critical reading goes unnoticed. This launch strengthens the companion diagnostics portfolio for Zydus in the Indian market.

Frequently Asked Questions

Q1: How often do the Diasens and GlucoLive devices update glucose readings?

The devices automatically stream glucose readings to the patient’s smartphone every three minutes, ensuring continuous and real-time monitoring.

Q2: What is the primary role of the AI layer in these CGM devices?

The AI layer analyzes data trends to flag hypo- and hyperglycaemic episodes while linking fluctuations to the patient's diet and activity levels.

Q3: Which app is used to view the data from these Zydus AI glucose monitors?

Patients use the TatvaCare GoodFlip app, which provides AI-driven analytics and connects them with clinicians and caregivers.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Zydus to launch AI-based glucose monitors - ETHealthworld


2. Zydus Lifesciences Official Product Announcement, March 2026.


3. The Role of AI in Continuous Glucose Monitoring for Chronic Disease Management.